Members of the Strategy Board
Since 2005 Emrah Düzel is at the Institute of Cognitive Neuroscience at University College London (UCL). He is professor of cognitive neuroscience (2008). In addition, Emrah Düzel is director of the Institute of Cognitive Neurology and Dementia Research at the University of Magdeburg and is an honorary member of the UCL Welcome Trust Centre for Neuroimaging. He conducts research at the level of the whole organism on the neuromodulatory and electrophysiological mechanisms of hippocampus-dependent memory in young and older adults and patients with various neurological diseases.
After several research stays at Harvard University, Boston USA and Massachusetts Institute of technology (Cambridge, USA), Prof. Fischer was leading a junior research group funded by the EURYI Award at the European Neuroscience Institute, Goettingen. The scientific results of this group were mainly responsible for the establishment of the new field of research neuroepigenetics in neurodegenerative diseases at the University Medical Center of Goettingen. Since 2011, Andre Fischer is Professor of the Medical Center of the University of Goettingen and Spokesman of the DZNE site Goettingen.His research focus in neurodegenerative diseases are molecular mechanisms of learning and memory, pathogenesis of neuropsychiatric diseases and anxiety disorders, epigenetic gene expression, profiling of gene expression and behavioral science with mouse models.
Peter Heutink was trained as a molecular biologist at the University of Amsterdam and performed his PhD at the department of Clinical Genetics of the Erasmus Medical Center Rotterdam. During his thesis work on the genetics of complex diseases he performed genome wide linkage scans for neuropsychiatric disorders and worked together with Prof Kidd from Yale University in 1989 to develop strategies for genetic studies for complex diseases. From 2003 to 2012 he was a full professor and head of the section Medical Genomics at VUmc Amsterdam. From 2007 to 2008 he was the director of the Institute for Clinical and Experimental Neurosciences (ICEN), VUmc, Amsterdam. In 2012, he became a group leader (Genome Biology of Neurodegenerative Diseases) at DZNE Tübingen and a professor at the Eberhard-Karls-University of Tübingen. Since 2013, he is the Site Speaker of the DZNE Tübingen.
Since 1999 Christian Haass heads the Department of Metabolic Biochemistry at the Adolf-Butenandt Institut of the Ludwig-Maximilians Universität in Munich (LMU). His main research area is decoding the molecular mechanisms of neurodegeneration – with a special emphasis on AD, Parkinson and Frontotemporal Dementia. Since 2000 he has been directing a DFG Collaborative Research Centre on "Molecular Mechanisms of Neurodegeneration" (SFB 596). Prof. Haass is member of the European Molecular Biology Organization (EMBO), the "Deutsche Akademie der Naturforscher Leopoldina" (National Academy of Sciences) and recepient of numerous awards include amongst others the Gottfried Wilhelm Leibniz-Prize of the Deutsche Forschungsgemeinschaft (DFG), the Potamkin Prize of the American Academy of Neurology and the MetLife Prize for medical research.
After completion of his medical studies at the Universities of Bonn and Göttingen in 1991, he worked as postdoctoral fellow at the Bremen Institute for Prevention Research and Social Medicine, Germany from 1992-2002. In 1993 he obtained his medical approbation and having defended his dissertation obtained his Dr. med from the University of Marburg, Germany in the same year. In 1995 he qualified for “Master of Public Health (MHP) in Epidemiology” at the Department of Epidemiology, University of North Carolina at Chapel Hill, United States of America. In 2002 Hoffmann was offered a BMBF-sponsored professorship and two years later a full professorship for Epidemiology of Health Care and Community Health at the Medical School of the Ernst-Moritz-Arndt-University Greifswald, Germany. Since 2007 he has been Acting Director of the Institute for Community Medicine. In 2011 he was offered a professorship for population based Epidemiology of Health Care and Community Health at the University Medicine Greifswald, Germany.
Since 2007 Gerd Kempermann is Professor for Genomics of Regeneration at the Center for Regenerative Therapies Dresden (CRTD). Before he had been group leader at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch. Since 2009 he has been the speaker of the DZNE site in Dresden. His research focuses on neural stem cells, in particular in relation to the generation of new neurons in the adult brain (adult neurogenesis) and its regulation by genes and physical as well as cognitive activity.
Martina Roes (born in 1961) studied sociology, philosophy and psychology at the Free University of Berlin and earned her degree in sociology. She received her PhD at the University of Applied Sciences in Bremen on the subject of “Knowledge Transfer in Nursing Care – A New Approach to Learning in Nursing Practice”. After a brief period in Göttingen, she joined the University of Applied Sciences in Bremen in 2003.
After his medical studies and PhD thesis at the University of Cologne and the Charité – Universitätsmedizin Berlin, Dietmar Schmitz continued his scientific carrier at the Charité and later at the University of California, San Francisco. In 2002 he returned to Germany as a junior research leader through the Emmy Noether Program and became Professor of Cellular and Molecular Neurosciences and Chair of the Neuroscience Research Center in 2005. From 2007- 2012 he coordinated the Cluster of Excellence NeuroCure and became speaker of the DZNE Berlin in 2011. In 2011 he was granted the first Einstein Professorship by the Einstein Foundation Berlin. His research focuses on synaptic transmission, synaptic plasticity and network function in health and disease.